Cartesian Therapeutics (RNAC) director Michael Singer gifts 6,555 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cartesian Therapeutics director Michael Singer reported a bona fide gift of 6,555 shares of Common Stock on March 13, 2026. The gift was made at no stated price and is classified as a non-market disposition rather than a sale.
After the gift, Singer directly holds 49,578 shares. He also reports additional indirect holdings in Cartesian Therapeutics through several trusts, a spouse account, and custodial accounts for his children under UTMA.
Positive
- None.
Negative
- None.
Insider Trade Summary
6,555 shares gifted
Mixed
7 txns
Insider
Singer Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 6,555 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 49,578 shares (Direct);
Common Stock — 383,796 shares (Indirect, by trust)
Footnotes (1)
- Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust. Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of the trust. Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of the trust. Shares are held by the reporting person's spouse. The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian. The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.
FAQ
What insider transaction did Michael Singer report for Cartesian Therapeutics (RNAC)?
Michael Singer reported a bona fide gift of 6,555 shares of Cartesian Therapeutics Common Stock on March 13, 2026. The transaction is coded “G,” meaning it is a gift disposition, not an open-market sale or purchase, and carried a reported price of $0.00 per share.
What indirect Cartesian Therapeutics (RNAC) holdings does Michael Singer report?
Michael Singer reports several indirect holdings, including 383,796 shares held by a trust benefiting his spouse and children, 56,719 shares in a trust where he is a beneficiary and trustee, 7,127 shares in another trust, 14,788 shares held by his spouse, and 96,219-share UTMA custodial accounts.
Does the Form 4 indicate any derivative securities for Cartesian Therapeutics (RNAC)?
The Form 4 derivative section is empty, indicating no derivative securities, such as options or warrants, are reported in this filing. All reported positions are in Cartesian Therapeutics Common Stock, split between direct ownership and several indirect holdings through trusts, spouse, and custodial accounts.
Cartesian